ScoreWhy is Glaxosmithkline Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.77% and Operating profit at 16.57% over the last 5 years
2
Flat results in Sep 25
- DEBTORS TURNOVER RATIO(HY) Lowest at 1.11 times
3
With ROE of 55.8, it has a Very Expensive valuation with a 24.8 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 7.69%, its profits have risen by 21.6% ; the PEG ratio of the company is 2.1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Glaxosmi. Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Glaxosmi. Pharma
7.49%
0.19
40.74%
Sensex
4.67%
0.40
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.77%
EBIT Growth (5y)
16.57%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-1.19
Sales to Capital Employed (avg)
2.02
Tax Ratio
26.50%
Dividend Payout Ratio
91.89%
Pledged Shares
0
Institutional Holding
12.55%
ROCE (avg)
-196.73%
ROE (avg)
59.34%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
44
Industry P/E
34
Price to Book Value
24.83
EV to EBIT
35.24
EV to EBITDA
33.31
EV to Capital Employed
-127.15
EV to Sales
10.89
PEG Ratio
2.06
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
55.83%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
ROCE(HY)
Highest at 69.55%
PBDIT(Q)
Highest at Rs 335.73 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 34.26%
-5What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.11 times
Loading Valuation Snapshot...
Here's what is working for Glaxosmi. Pharma
Operating Profit (PBDIT) - Quarterly
Highest at Rs 335.73 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 34.26%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Here's what is not working for Glaxosmi. Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 1.11 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
